Who Paid My Doc
Lumoxiti
Drug Oncology
NDC 0310-4700-01
General payments
$138,495
Research payments
$147,144
Through program year 2020, $138,495 in general payments and $147,144 in research payments were reported against Lumoxiti (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $3,425 | 2 |
| 2020 | Research | $36,702 | 3 |
| 2019 | General | $135,070 | 71 |
| 2019 | Research | $110,442 | 7 |
Breakdown
Each share is of general payments naming this product in 2020.
Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2020 where a state was reported.
Records
73 general · 10 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.